04:25 PM, 12th May 2023
Dear Sir/MadamThis is further to our letter dated 10th May 2023 intimating about the date of the Board of Directors Meeting to inter alia consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended 31 March 2023.We wish to inform that pursuant to regulation 30 and other applicable regulations if any of the SEBI (LODR) Regulations 2015 the Company will hold a conference call for analysts and investors on Wednesday 17th May 2023 at 05:00 p.m. IST. The details of the said call are attached herewith and also available on Companys website.Thanking you.For Eris Lifesciences Limited